


| Key | % Net Assets |
|---|---|
| 5.7% | |
| 5.6% | |
| 4.4% | |
| 3.8% | |
| 80.5% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 5.7% |
| Royal Dutch Shell | 5.6% |
| Vodafone | 4.4% |
| British American Tobacco | 3.8% |
| Unilever | 2.9% |
| British American Tobacco | 2.8% |
| BT Group | 2.7% |
| Imperial Tobacco | 2.7% |
| HSBC Holdings | 2.5% |
| Centrica | 2.2% |
No asset data available.
| Date | 09-May-2022 |
|---|---|
| NAV | 266.40p |
| Currency | GBP |
| Change | -6.20p |
| % | -2.27% |
| YTD change | 266.40p |
| YTD % | n/a |
| Fund Inception | 18/10/2004 |
|---|---|
| Fund Manager | n/a |
| TER | 1.81 (31-Mar-2014) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.70% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.11 |
You are here: research